"Brain Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Descriptor ID |
D001932
|
| MeSH Number(s) |
C04.588.614.250.195 C10.228.140.211 C10.551.240.250
|
| Concept/Terms |
Brain Neoplasms- Brain Neoplasms
- Neoplasms, Brain
- Brain Neoplasm
- Neoplasm, Brain
- Brain Tumors
- Brain Tumor
- Tumor, Brain
- Tumors, Brain
Brain Cancer- Brain Cancer
- Brain Cancers
- Cancer, Brain
- Cancers, Brain
- Malignant Neoplasms, Brain
- Brain Malignant Neoplasm
- Brain Malignant Neoplasms
- Malignant Neoplasm, Brain
- Cancer of Brain
- Cancer of the Brain
- Neoplasms, Brain, Malignant
- Brain Neoplasms, Malignant
- Brain Neoplasm, Malignant
- Malignant Brain Neoplasm
- Malignant Brain Neoplasms
Brain Tumor, Recurrent- Brain Tumor, Recurrent
- Brain Tumors, Recurrent
- Recurrent Brain Tumor
- Recurrent Brain Tumors
Malignant Primary Brain Tumors- Malignant Primary Brain Tumors
- Primary Malignant Brain Tumors
- Malignant Primary Brain Neoplasms
- Primary Malignant Brain Neoplasms
- Brain Neoplasms, Malignant, Primary
- Brain Neoplasms, Primary Malignant
Benign Neoplasms, Brain- Benign Neoplasms, Brain
- Benign Neoplasm, Brain
- Brain Benign Neoplasm
- Brain Benign Neoplasms
- Neoplasms, Brain, Benign
- Brain Neoplasms, Benign
- Benign Brain Neoplasm
- Benign Brain Neoplasms
- Brain Neoplasm, Benign
Brain Tumor, Primary- Brain Tumor, Primary
- Brain Tumors, Primary
- Primary Brain Tumor
- Primary Brain Tumors
- Neoplasms, Brain, Primary
- Brain Neoplasm, Primary
- Brain Neoplasms, Primary
- Primary Brain Neoplasm
- Primary Brain Neoplasms
|
Below are MeSH descriptors whose meaning is more general than "Brain Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Brain Neoplasms".
This graph shows the total number of publications written about "Brain Neoplasms" by people in this website by year, and whether "Brain Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 11 | 1 | 12 |
| 1997 | 5 | 2 | 7 |
| 1998 | 3 | 2 | 5 |
| 1999 | 2 | 3 | 5 |
| 2000 | 11 | 1 | 12 |
| 2001 | 4 | 1 | 5 |
| 2002 | 9 | 2 | 11 |
| 2003 | 10 | 6 | 16 |
| 2004 | 14 | 2 | 16 |
| 2005 | 9 | 2 | 11 |
| 2006 | 5 | 1 | 6 |
| 2007 | 16 | 4 | 20 |
| 2008 | 18 | 3 | 21 |
| 2009 | 14 | 2 | 16 |
| 2010 | 31 | 3 | 34 |
| 2011 | 18 | 2 | 20 |
| 2012 | 25 | 1 | 26 |
| 2013 | 29 | 4 | 33 |
| 2014 | 38 | 5 | 43 |
| 2015 | 39 | 4 | 43 |
| 2016 | 34 | 2 | 36 |
| 2017 | 40 | 3 | 43 |
| 2018 | 36 | 5 | 41 |
| 2019 | 54 | 2 | 56 |
| 2020 | 36 | 5 | 41 |
| 2021 | 44 | 0 | 44 |
| 2022 | 30 | 3 | 33 |
| 2023 | 40 | 2 | 42 |
| 2024 | 33 | 11 | 44 |
| 2025 | 46 | 1 | 47 |
| 2026 | 17 | 1 | 18 |
To return to the timeline,
click here.
Below are the most recent publications written about "Brain Neoplasms" by people in Profiles.
-
Inaccurate interpretation of hypoxia signatures from transcriptomic analyses in neuro-oncology. Neoplasia. 2026 09; 79:101327.
-
Hp1bp3 loss links chromatin reorganization to metabolic vulnerability in glioma. Proc Natl Acad Sci U S A. 2026 Jun 16; 123(24):e2601061123.
-
Androgen activity in the male embryonic hindbrain drives lethal PFA ependymoma. Nature. 2026 04; 652(8110):763-773.
-
EZHIP boosts neuronal-like synaptic gene programs and depresses polyamine metabolism. Acta Neuropathol Commun. 2025 11 07; 13(1):227.
-
Genomic determinants of the diffusely infiltrative gliomatosis cerebri phenotype. J Neurooncol. 2025 Oct 16; 176(1):19.
-
Co-occurrence of congenital anomalies and childhood brain tumors in 22 million live births. Neuro Oncol. 2025 Sep 08; 27(7):1910-1922.
-
Molecular and clinical determinants of response to checkpoint inhibitor immunotherapy in glioblastoma. J Neurooncol. 2025 Oct; 175(1):453-461.
-
Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825. Neuro Oncol. 2025 Mar 07; 27(3):767-778.
-
Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas. Nature. 2025 01; 637(8046):708-715.
-
CASCADES, a novel SOX2 super-enhancer-associated long noncoding RNA, regulates cancer stem cell specification and differentiation in glioblastoma. Mol Oncol. 2025 Mar; 19(3):764-784.